FDA approves Cervarix human papilloma vaccine as cervical cancer deterrent [Updated] | Booster Shots | Los Angeles Times
Links shared publicly online about this topic.
- 1,672total visits
FDA approves Cervarix human papilloma vaccine as cervical cancer deterrent [Updated] | Booster Shots | Los Angeles Times
The food and drug administration today approved cervarix, the vaccine against human papilloma virus (hpv) manufactured by glaxosmithkline, for use in girls and young women ages 10 to 25. an fda adivsory panel recommended approval of the vaccine on sept....
View full resource at latimesblogs.latimes.com
Tags: Cervical Cancer Prevention, Drug, Women's Health, FDA, Vaccine, HPV Vaccine, Cervarix, GlaxoSmithKline
Most Recently Shared on October 19, 2009 at 11:25 am By:
FDA approved Cervarix, 2nd HPV vaccine, for young women to prevent cervical cancer. http://bit.ly/m1QDg
Also Shared By:
Advertisement
LA Times Health News
@latimeshealth
FDA approves Cervarix human papilloma vaccine as cervical cancer deterrent http://bit.ly/3NhY9x
1 year ago...